Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • terry_amln terry_amln Nov 14, 2010 8:15 AM Flag

    IGF-1 for HARS/HAMS Review Article

    You take info and twist it to pump and throw in conjecture.Iplex's results were weak in Insmeds Phase 2 trial and the company dropped it as opposed to your "reading".
    REAL drugs and candidates are out there many many years and many manufacturers ahead.

    Last week the FDA Approved a New Drug For HIV Lipodystrophy and Amylin is going to file a rolling NDA this year for its own Orphan Drug Candidate to treat Lipdystrophy There are many approved drugs that are approved and used to improve lipids triglycerides and weight control etc.Byetta is one of them and does a far better job than Iplex .

    It's time to get real about Insmeds possibilities."reading " into a piece and making conclusions without a biotechnology or medical background is disingenuous.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
12.78-0.60(-4.48%)Feb 5 4:00 PMEST